← FDA DRUG APPROVALS

FDA ANDA · ANDA212227

GLYCOPYRROLATE 1ML

glycopyrrolate

Sponsor: XIROMED

APPLICATION
ANDA212227
TYPE
ANDA
ORIGINAL APPROVAL
2021-03-04
LATEST ACTION
2021-03-04
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

GLYCOPYRROLATEDiscontinued
GLYCOPYRROLATE 0.2MG/ML · INJECTABLE · INJECTION

Approval history

2021-03-04UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →